• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左乙拉西坦在癫痫治疗中的作用。

Role of levetiracetam in the treatment of epilepsy.

作者信息

Brodie Martin J, French Jacqueline A

机构信息

Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, Scotland, United Kingdom.

出版信息

Epileptic Disord. 2003 May;5 Suppl 1:S65-72.

PMID:12915344
Abstract

Physicians treating patients with epilepsy have a host of thera-peutic options. Drug choice is dictated first by the seizure(s) and/or epilepsy syndrome. Age is also a factor. Special considerations apply to women, particu-larly during their childbearing years, and to patients who are learning-disabled. Drug selection is further influenced by such characteristics as spectrum of activity, rapid response, low potential for drug-drug interactions, and ease of use. In addition to clinical trial data, postmarketing assessments of the new antiepileptic drugs provide useful clinical information on efficacy and safety. Levetiracetam has specific characteristics that make it an optimal choice for many patient populations.

摘要

治疗癫痫患者的医生有许多治疗选择。药物选择首先取决于癫痫发作和/或癫痫综合征。年龄也是一个因素。对于女性,尤其是在育龄期,以及有学习障碍的患者,有特殊的考虑因素。药物选择还会受到活性谱、快速反应、药物相互作用可能性低和使用方便等特性的影响。除了临床试验数据外,新型抗癫痫药物的上市后评估也提供了关于疗效和安全性的有用临床信息。左乙拉西坦具有特定的特性,使其成为许多患者群体的最佳选择。

相似文献

1
Role of levetiracetam in the treatment of epilepsy.左乙拉西坦在癫痫治疗中的作用。
Epileptic Disord. 2003 May;5 Suppl 1:S65-72.
2
Safety profile of levetiracetam.左乙拉西坦的安全性概况。
Epileptic Disord. 2003 May;5 Suppl 1:S57-63.
3
Preliminary efficacy of levetiracetam in monotherapy.左乙拉西坦单药治疗的初步疗效。
Epileptic Disord. 2003 May;5 Suppl 1:S51-5.
4
Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.左乙拉西坦在临床实践中的应用:转诊至三级癫痫中心的难治性癫痫患者的长期经验。
Epilepsy Behav. 2007 Mar;10(2):296-303. doi: 10.1016/j.yebeh.2006.11.016. Epub 2007 Feb 20.
5
Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.左乙拉西坦作为难治性癫痫的附加疗法在4岁以下儿童中的疗效和安全性。
J Child Neurol. 2010 May;25(5):609-13. doi: 10.1177/0883073809342489. Epub 2009 Sep 24.
6
Levetiracetam: preliminary efficacy in generalized seizures.左乙拉西坦:对全身性癫痫发作的初步疗效
Epileptic Disord. 2003 May;5 Suppl 1:S39-44.
7
Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.添加左乙拉西坦治疗儿童和青少年难治性癫痫:一项开放标签多中心研究的结果
Eur J Paediatr Neurol. 2008 Jul;12(4):321-7. doi: 10.1016/j.ejpn.2007.09.004. Epub 2007 Oct 18.
8
Long-term experience with levetiracetam.
Epileptic Disord. 2003 May;5 Suppl 1:S33-7.
9
The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
Epilepsia. 2008 Jul;49(7):1174-9. doi: 10.1111/j.1528-1167.2008.01585.x.
10
Levetiracetam in the treatment of idiopathic generalized epilepsies.左乙拉西坦治疗特发性全身性癫痫
Epilepsia. 2005;46 Suppl 9:154-60. doi: 10.1111/j.1528-1167.2005.00329.x.

引用本文的文献

1
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.突触小泡糖蛋白2A配体在癫痫及其他疾病治疗中的应用
CNS Drugs. 2016 Nov;30(11):1055-1077. doi: 10.1007/s40263-016-0384-x.